2023-11-25 19:12:01

Omicron boosters probably aren't very effective against mild Covid illness, but will likely prevent hospitalizations,...

Logo CNBC
CNBC
By Spencer Kimball

Key Points

  • The CDC, in a real-world study, found the omicron Covid boosters are less than 50% effective against mild illness across almost all adult age groups when compared to people who are unvaccinated.
  • But people who received the boosters were better off than those who only got the old shots, with their protection increasing 28% to 56%.
  • The study did not look at hospitalization, but experts believe the shots will provide strong protection against severe outcomes.

A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022.

AD
AD

Vanessa Leroy | Bloomberg | Getty Images

The new omicron Covid boosters probably aren't very effective at preventing Covid infections and mild illness, but they will likely help keep the elderly and other vulnerable groups out of the hospital this winter, experts say.

The Centers for Disease Control and Prevention, in a real-world study published this week, found the boosters are less than 50% effective against mild illness across almost all adult age groups when compared to people who are unvaccinated.

Continue read on cnbc.com

AD
Logo U.S. News & World Report
PoliticsBy Associated Press2023-11-25 14:00:07
By LAURA UNGAR, AP Science Writer A year after omicron began its assault on humanity, the ever-morphing coronavirus mutant drove COVID-19 case counts higher...

Logo CNBC
Business / FinanceBy Spencer Kimball2023-11-25 17:46:33
Key Points The omicron BQ coronavirus subvariants have risen to dominance in the U.S. as people gather and travel for the Thanksgiving holiday, putting...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-11-22 16:51:28
By LAURAN NEERGAARD, AP Medical Writer Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who...

Logo WJXT
PoliticsBy Associated Press2023-11-22 16:51:28
Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who havent at least for now, U.S. health...

Logo U.S. News & World Report
PoliticsBy Health Day2023-11-25 14:00:00
By Cara Murez HealthDay Reporter FRIDAY, Nov. 25, 2022 (HealthDay News) -- When COVID-19 restrictions lifted in the United Kingdom, the risk for severe...

Logo Global News
PoliticsBy Aaron D'andrea2023-11-25 17:35:02
Dr. Laura Hawryluck says she felt something more was coming. In November 2021, the Toronto-based critical care doctor had just experienced the toll COVID-19s...

Logo MarketWatch
MarketsBy Ciara Linnane2023-11-23 15:28:00
The U.S. is unlikely to suffer the same surge of COVID-19 infections this winter as it did last year, when the omicron variant first emerged and swept across...

Logo MarketWatch
MarketsBy Jaimy Lee2023-11-23 12:31:00
As we head into the third winter of the pandemic, only about 13% of American adults less than 11% of Americans overall have received the bivalent COVID-19...

Logo U.S. News & World Report
PoliticsBy Health Day2023-11-23 13:00:00
By Cara Murez HealthDay Reporter WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Even if you've already had COVID-19, you can still benefit from a vaccine that...

Logo U.S. News & World Report
PoliticsBy Health Day2023-11-18 18:43:00
By Robin Foster HealthDay Reporter FRIDAY, Nov. 18, 2022 (HealthDay News) -- Pfizer's updated COVID booster shots are proving their mettle against emerging...

Logo Benzinga
MarketsBy Vandana Singh2023-11-25 16:18:13
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection. The two-dose vaccine employs...

Logo CNBC
Business / FinanceBy Spencer Kimball2023-11-14 15:40:38
Key Points Moderna found that the new booster triggered five times more antibodies against omicron BA.5 than the old vaccines in people with prior Covid...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-11-18 15:30:14
By LAURAN NEERGAARD, AP Medical Writer Pfizer said Friday that its updated COVID-19 booster may offer some protection against newly emerging omicron mutants...

Logo U.S. News & World Report
PoliticsBy Health Day2023-11-23 13:17:00
By Cara Murez HealthDay Reporter WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Its not too late to get the latest COVID-19 booster shot. Whether its the...

Logo Fortune
Business / FinanceBy Erin Prater2023-11-18 20:17:07
It's relatively good news for everyone except the immunocompromised.

Logo U.S. News & World Report
PoliticsBy Cecelia Smith Schoenwalder2023-11-18 21:16:48
A pair of rapidly spreading omicron subvariants have overtaken BA.5 as the dominant COVID-19 strains circulating in the U.S., according to data from the...

Logo CNBC
Business / FinanceBy Spencer Kimball2023-11-18 15:51:59
Key Points Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared to a fourth...

Logo Bloomberg
MarketsBy Shirley Zhao2023-11-25 03:32:50
China’s daily Covid infections broke through 30,000 for the first time ever as officials struggle to contain outbreaks that have triggered a growing number...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-11-25 17:06:59
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class...

Logo U.S. News & World Report
PoliticsBy Health Day2023-11-14 17:46:00
By Cara Murez HealthDay Reporter MONDAY, Nov. 14, 2022 (HealthDay News) -- Moderna, Inc., announced Monday that its updated booster shot triggers strong...